It has been reported that this FRB supplementation inhibits TNF-α expression in DSS-induced inflammation [35] in chronic colitis-associated extraintestinal manifestations [34] and in streptozotocin-induced diabetic rats [36]. The gene discussed is TNF; the disease is Chronic colitis.